Evaluation of PTH Level at 26 pg/mL
A PTH level of 26 pg/mL requires immediate assessment of serum calcium, vitamin D status, and renal function to determine whether this represents normal physiology, secondary hyperparathyroidism, or normocalcemic primary hyperparathyroidism. 1
Initial Diagnostic Approach
Measure serum calcium (corrected for albumin or ionized) and 25-hydroxyvitamin D on the same blood sample as the PTH measurement. 2 The interpretation of PTH is meaningless without simultaneous calcium assessment, as PTH must be interpreted in the context of calcium levels 3.
If Calcium is Elevated (Hypercalcemia):
PTH of 26 pg/mL in the setting of hypercalcemia is inappropriately normal and diagnostic of primary hyperparathyroidism. 2, 1 In classic PHPT, PTH does not need to be frankly elevated—it simply needs to be "inappropriately normal" (not suppressed) in the presence of high calcium 2.
Calculate the fractional excretion of calcium (FeCa) to exclude familial hypocalciuric hypercalcemia. 2 A FeCa >2% supports PHPT, while <1% suggests FHH.
Assess for target organ complications: Check 24-hour urine calcium (hypercalciuria >300 mg/day in men, >250 mg/day in women increases kidney stone risk), renal function, and bone density 2.
If Calcium is Normal (Normocalcemia):
This scenario requires systematic exclusion of secondary causes before considering normocalcemic primary hyperparathyroidism (NPHPT). 4
Mandatory Secondary Hyperparathyroidism Workup:
Check 25-hydroxyvitamin D levels immediately. 2, 4 Vitamin D deficiency or insufficiency is the most common cause of elevated PTH with normal calcium and must be corrected before diagnosing NPHPT 3, 4.
Assess renal function (eGFR and creatinine). 3 Even mild chronic kidney disease can elevate PTH through phosphate retention and impaired vitamin D activation 3.
Measure serum phosphate. 2 Low phosphate with normal calcium may suggest early PHPT, while high phosphate suggests renal dysfunction 3.
Review medications: Thiazide diuretics, lithium, loop diuretics, bisphosphonates, and proton pump inhibitors can all elevate PTH 4.
Evaluate for malabsorption: Bariatric surgery, celiac disease, and inflammatory bowel disease cause secondary hyperparathyroidism 4.
Check magnesium levels: Hypomagnesemia impairs PTH secretion and action 4.
If All Secondary Causes Are Excluded:
Consider normocalcemic primary hyperparathyroidism only after repeated measurements confirm persistent elevation of PTH with consistently normal calcium over 3-6 months. 4 NPHPT is a diagnosis of exclusion and should be made cautiously, as many patients will normalize PTH once vitamin D is repleted 4.
Critical Assay Considerations
PTH results must be interpreted using the specific reference range for the assay used by your laboratory. 3, 1 Different PTH assays (second-generation vs. third-generation) measure different PTH fragments and lack standardization, leading to significant inter-assay variability 3. A PTH of 26 pg/mL may be normal, low, or high depending on the assay and laboratory reference range 3.
Key factors affecting PTH measurement include: 3
- Age (PTH increases with age due to declining GFR)
- Race (higher in Black individuals)
- BMI (higher in obesity)
- Time of sampling (PTH has circadian variation)
- Sample type (more stable in EDTA plasma than serum)
Common Pitfalls to Avoid
Never interpret PTH without simultaneous calcium measurement. 2, 1 A single elevated PTH with normal calcium on different days is insufficient for diagnosis.
Do not diagnose NPHPT without first correcting vitamin D deficiency. 4 Replete vitamin D to >30 ng/mL and remeasure PTH after 3 months.
Avoid using PTH cutoffs from one laboratory when results come from another. 3 Always use assay-specific reference ranges.
Do not assume PTH of 26 pg/mL is abnormal without knowing your laboratory's reference range. 3 In some assays, this may be within normal limits, particularly if the upper limit of normal is 65-70 pg/mL 5.
Clinical Significance by Context
In a patient with known hypercalcemia, PTH >26 pg/mL essentially rules out PTH-related peptide (PTHrP)-mediated hypercalcemia of malignancy. 5 A PTH cutoff >26 ng/L (pg/mL) predicted a non-elevated PTHrP result in 100% of hypercalcemic patients, making PTHrP testing unnecessary 5.
In post-parathyroidectomy patients, PTH of 26 pg/mL with normal calcium is not concerning. 6, 7, 8 Up to 25-40% of patients have persistently elevated PTH after successful parathyroidectomy, which typically normalizes over months to years and does not indicate recurrent disease unless calcium rises above 9.7 mg/dL 6, 7, 8.